Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Medtronic
Express Scripts
McKesson
Citi
Boehringer Ingelheim
Harvard Business School
Teva
Accenture

Generated: July 21, 2018

DrugPatentWatch Database Preview

Flunisolide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for flunisolide and what is the scope of flunisolide patent protection?

Flunisolide
is the generic ingredient in five branded drugs marketed by Roche Palo, Mylan Speciality Lp, Apotex Inc, Bausch And Lomb, Hi Tech Pharma Co, Ivax Res, and Teva Branded Pharm, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for flunisolide. Five suppliers are listed for this compound.
Pharmacology for flunisolide
Synonyms for flunisolide
(1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0;{2,9}.0;{4,8}.0;{13,18}]icosa-14,17-dien-16-one
(1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-FLUORO-11-HYDROXY-8-(2-HYDROXYACETYL)-6,6,9,13-TETRAMETHYL-5,7-DIOXAPENTACYCLO[10.8.0.0(2),?.0?,?.0(1)(3),(1)?]ICOSA-14,17-DIEN-16-ONE
(6a,11b,16a)-6-Fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione
32277-EP2281815A1
32277-EP2295402A2
32277-EP2301933A1
32277-EP2305640A2
32277-EP2308562A2
32277-EP2311827A1
32277-EP2371811A2
3385-03-3
385F033
6 alpha-fluoro-11 beta,16 alpha,17,21- tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16, 17-acetal with acetone
6 alpha-fluorodihydroxy-16 alpha,17 alpha-isopropylidenedioxy-1,4-pregnadiene-3,20- dione
6-Fluoro-11,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,17-acetonide
6-Fluoro-11,21-dihydroxy-16,17-(isopropylidenedioxy)pregna-1,4-diene-3,20-dione
6alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16, 17-acetal with acetone
77326-96-6
78M02AA8KF
AB1010905
ABP000528
AC-3514
AC1L32UV
Aerobid
Aerobid M
Aerospan
AKOS025402038
AN-12914
BCP9000696
BPBio1_000711
BRD-K49577446-001-03-1
Bronalide
BSPBio_000645
C07005
CAS-3385-03-3
CCG-220643
CHEBI:5106
CHEMBL1512
CS-4713
DB00180
DSSTox_CID_25534
DSSTox_GSID_45534
DSSTox_RID_80936
DTXSID1045534
EINECS 222-193-2
Flunie
Flunisolida
Flunisolida [INN-Spanish]
Flunisolide (anhydrous)
Flunisolide [anhydrous]
Flunisolide [INN]
Flunisolide Hemihydrate
Flunisolide HFA
Flunisolide(Nasalide)/
Flunisolidum
Flunisolidum [INN-Latin]
GTPL7076
HMS1570A07
HMS2097A07
HMS2236A06
HMS3259L10
HY-B1121
LS-118464
Lunis
lunisolide anhydrous
MFCD00133324
MLS002153928
MolPort-005-943-434
Nasalide
Nasarel
NC00716
NCGC00016983-01
NCGC00179492-01
NCGC00179492-03
Nisolid
PL000385
Pregna-1,4-diene-3,20-dione, 6-alpha-fluoro-11-beta,16-alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone
Pregna-1,4-diene-3,20-dione, 6-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-
Prestwick_223
Prestwick0_000643
Prestwick1_000643
Prestwick2_000643
Prestwick3_000643
Q834
Rhinalar
RS 3999
RS-3999
SCHEMBL4351
SMR001233272
Soluzione
SPBio_002566
Synaclyn
Syntaris
Tox21_110725
Tox21_110725_1
UNII-78M02AA8KF
ZINC4097305

US Patents and Regulatory Information for flunisolide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp AEROSPAN HFA flunisolide AEROSOL, METERED;INHALATION 021247-001 Jan 27, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Res NASALIDE flunisolide SPRAY, METERED;NASAL 018148-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche Palo AEROBID flunisolide AEROSOL, METERED;INHALATION 018340-001 Aug 17, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for flunisolide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 ➤ Sign Up ➤ Sign Up
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 ➤ Sign Up ➤ Sign Up
Roche Palo AEROBID flunisolide AEROSOL, METERED;INHALATION 018340-001 Aug 17, 1984 ➤ Sign Up ➤ Sign Up
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Express Scripts
Mallinckrodt
Queensland Health
Argus Health
Cipla
Federal Trade Commission
McKesson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.